Abstract
The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of combining anatomical and functional information and is becoming a valuable tool in oncology, in particular for staging purposes. DWI may prove to be a useful biomarker in clinical decision making for patients with lymphoma. Large-scaled prospective studies are needed to confirm these preliminary results.
Original language | English |
---|---|
Pages (from-to) | S172-S178 |
Journal | Cancer Imaging |
Volume | 10 |
Issue number | SPEC. ISS. A |
DOIs | |
State | Published - 2010 |
Externally published | Yes |
Keywords
- FDG-PET/CT
- Lymphoma
- Response assessment
- Staging
- Whole-body DWI